IV
Publicaties op Oncologisch.com
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Gevorderd Breast Cancer.
Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients.
Body mass index and weight changes in patiënten met HER2-positive early breast cancer: A sub-analysis of the APHINITY...
Zwangerschap na mammacarcinoom: systematische review en meta-analyse
Eribuline met of zonder pembrolizumab bij HR-positief mammacarcinoom: fase II